Hot Pursuit     22-Mar-25
Alembic Pharma’s Gujarat facility clears USFDA inspection
Alembic Pharmaceuticals said that its API–III facility located at Karakhadi, Gujarat, has successfully cleared the US Food and Drug Administration (USFDA) inspection with zero observations.
The inspection was conducted from 17th March to 21st March, 2025. This was a scheduled GMP inspection and was successfully completed without any Form 483 observation.

Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company, has been at the forefront of healthcare since 1907. Headquartered in India, Alembic is a publicly listed company that manufactures and markets generic pharmaceutical products all over the world.

The company’s consolidated net profit tumbled 23.29% to Rs 138.42 crore in Q3 FY25, compared with Rs 180.45 crore posted in Q3 FY24. Revenue from operations was at Rs 1,692.74 crore in the third quarter of FY25, up 3.81% year on year (YoY).

The counter surged 13.62% to end at Rs 947.75 on the BSE on Friday.

Previous News
  Alembic Pharmaceuticals commissions new facility at Pithampur, Madhya Pradesh
 ( Corporate News - 26-Apr-25   14:24 )
  Alembic Pharmaceuticals to conduct board meeting
 ( Corporate News - 19-Apr-25   10:36 )
  Alembic Pharma receives final approval for Carbamazepine tablets
 ( Hot Pursuit - 17-Apr-25   12:13 )
  Alembic Pharmaceuticals receives USFDA approval for Carbamazepine Tablets
 ( Corporate News - 17-Apr-25   12:08 )
  Alembic Pharmaceuticals receives USFDA approval for Pantoprazole sodium for injection
 ( Corporate News - 02-Apr-25   11:16 )
  Alembic Pharma receives USFDA final approval for Pantoprazole Sodium Injection
 ( Hot Pursuit - 01-Apr-25   13:17 )
  Indices drift higher in early trade; breadth strong
 ( Market Commentary - Mid-Session 24-Mar-25   09:34 )
  Stock Alert: Alembic Pharma, L&T, RIL, M&M, Godrej Properties
 ( Market Commentary - Stock Alert 24-Mar-25   08:37 )
  Alembic Pharma’s Gujarat facility clears USFDA inspection
 ( Hot Pursuit - 22-Mar-25   09:03 )
  Volumes spurt at Alembic Pharmaceuticals Ltd counter
 ( Hot Pursuit - 21-Mar-25   14:30 )
  Alembic Pharma's Vadodara facility gets one Form 483 observation from US FDA
 ( Hot Pursuit - 08-Mar-25   12:53 )
Other Stories
  Kamat Hotels Q4 PAT surges 412% YoY to Rs 11 cr
  26-Apr-25   16:21
  Bank of Maharashtra Q4 PAT climbs 23% YoY to Rs 1,493 crore
  26-Apr-25   15:34
  Oracle Financial Services Software Q4 PAT up 19% QoQ
  26-Apr-25   14:28
  Force Motors Q4 PAT surges 210% YoY to Rs 435 cr; declares dividend of Rs 40/sh
  26-Apr-25   14:02
  L&T Finance Q4 PAT rises 15% YoY to Rs 636 crore
  26-Apr-25   13:31
  RBL Bank PAT drops 81% YoY to Rs 69 crore in Q4 FY25; provisions zoom by 90% YoY
  26-Apr-25   12:12
  Tejas Networks reports dismal Q4 outcome
  26-Apr-25   11:54
  Zydus Life gets 6 observations from USFDA for API plant
  26-Apr-25   11:02
  RIL Q4 PAT rises 6.4% YoY
  26-Apr-25   10:05
  Tata Technologies Q4 PAT climbs 12% QoQ to Rs 189 cr
  25-Apr-25   17:34
Back Top